Lu 29-252

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Lu 29-252 is a selective sigma σ 2 receptor ligand which was under development for the treatment of anxiety disorders but was never marketed. It reached the preclinical stage of development prior to the discontinuation of its development. The drug was under development by Lundbeck.

Lu 29-252 is a selective sigma σ 2 receptor ligand which was under development for the treatment of anxiety disorders but was never marketed. It reached the preclinical stage of development prior to the discontinuation of its development. The drug was under development by Lundbeck.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1372022373 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.